A detailed history of Comerica Bank transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Comerica Bank holds 3,419 shares of MRVI stock, worth $16,958. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,419
Previous 2,066 65.49%
Holding current value
$16,958
Previous $14,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.84 - $9.73 $9,254 - $13,164
1,353 Added 65.49%
3,419 $28,000
Q2 2024

Aug 15, 2024

SELL
$6.87 - $11.34 $20 - $34
-3 Reduced 0.14%
2,066 $14,000
Q1 2024

May 15, 2024

SELL
$5.11 - $8.76 $2,181 - $3,740
-427 Reduced 17.11%
2,069 $17,000
Q4 2023

Feb 14, 2024

SELL
$4.7 - $9.87 $2,176 - $4,569
-463 Reduced 15.65%
2,496 $16,000
Q3 2023

Nov 21, 2023

BUY
$9.14 - $12.85 $13,920 - $19,570
1,523 Added 106.06%
2,959 $29,000
Q2 2023

Aug 22, 2023

BUY
$12.09 - $15.0 $17,361 - $21,540
1,436 New
1,436 $6,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $652M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.